Medtronic (MDT): FY25 Q2 earnings call, Nov 19, 2024
No Kalshi or Polymarket word markets were listed for Medtronic’s Nov 19, 2024 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
5 matches for “Sphere-9”; 4 quoted, at least 25 words apart.
…FDA approval late last month for Affera mapping and ablation system, and Sphere-9 focal catheter. This all-in-one catheter was designed from the ground up to…
…which had the supplier issue this quarter, and the upcoming or ongoing Sphere-9, Affera launch, and Hugo robotic and renal denervation. Maybe you could just…
…to continue to ramp. We have this -- and now we have Sphere-9, and that gives us all this combined the supplier issue should being…
…it's certainly more, and that that correlates to too, is with the Sphere-9 catheter since you don't need a dedicated mapping catheter, it actually saves…
Agents: this page as TSV at /api/v1/appearances/medtronic:2024-11-19:earnings_call · words: /api/v1/brief?appearance=medtronic:2024-11-19:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP